Inventory of Complicated Grief
- Introduced by
- Holly G. Prigerson
- Year
- 1995
- Type
- Self-report questionnaire
- Family
- diagnosis-focused-grief-assessment
What does it do?
The Inventory of Complicated Grief (ICG) is a 19-item self-report measure developed by Prigerson and colleagues in 1995 to assess complicated grief—a persistent, impairing form of grief that goes beyond typical bereavement.
Designed to distinguish complicated grief from bereavement-related depression, the ICG has become the gold-standard screening and diagnostic instrument in bereavement research and clinical practice.
The intuition behind the method
Complicated grief (now termed Prolonged Grief Disorder in DSM-5-TR) is characterized by persistent yearning, intrusive thoughts about the deceased, difficulty accepting death, emotional numbness, and impaired functioning that persists 6–12 months or longer after loss. Unlike normal grief, which gradually resolves over time, complicated grief involves a 'stuck' psychological state marked by intense longing and preoccupation with the deceased. The ICG captures the diagnostic hallmarks of this condition, allowing clinicians and researchers to distinguish pathological grief from normative bereavement.
History
Developed by Holly G. Prigerson and colleagues in 1995 at Yale University School of Medicine, the ICG was originally designed to distinguish complicated grief from bereavement-related depression and anxiety in a sample of elderly bereaved spouses. The psychometric study (N=205) demonstrated that complicated grief is a distinct diagnostic entity requiring targeted treatment. Subsequent validation studies in diverse populations (bereaved parents, adolescents, young adults) and across cultures have confirmed the ICG's utility. The scale's clinical relevance increased with DSM-5-TR (2013) and ICD-11 (2022), both of which formalized Prolonged Grief Disorder as a diagnosis; ICG items map directly onto these criteria. The measure has been used in over 300 published studies and remains the most widely-used screening instrument for complicated grief internationally.
When to use it
The ICG is indicated in bereaved individuals 6+ months post-loss who present with persistent, impairing grief symptoms. Primary settings include: grief counselling and psychotherapy services; psychiatric and primary care clinics screening for complicated grief in bereaved patients; bereavement research studies; follow-up assessment after major loss (death of spouse, child, parent); and early identification of high-risk individuals who may benefit from targeted interventions. Particularly valuable in populations at risk for prolonged or complicated grief (e.g., loss of a child, sudden/violent death, concurrent stressors).
Limitations and considerations
- Does not assess protective factors (meaning-making, post-loss growth) that characterize resilience in bereavement; focuses exclusively on pathology.
- Cutoff score of 25 may not be universally optimal; some studies suggest context- or population-specific thresholds (e.g., higher cutoff in early grief, lower in protracted grief).
- Limited cultural validation; primarily normed in Western, predominantly white populations; may require adaptation for diverse cultural grief expressions.
- Cannot diagnose complicated grief independently; requires clinical judgment regarding symptom onset, duration, and functional impairment to meet DSM-5-TR criteria.
- Time window (past 2 weeks) is short; may not capture fluctuations in grief intensity over longer periods or distinguish acute exacerbations from baseline complicated grief.
Source conditions do not replace independent scientific review or validation by an analysis engine.
Strengths
- Well-validated in multiple populations (bereaved spouses, parents, adolescents) with strong psychometric properties (Cronbach's α typically >0.80, test-retest reliability r>0.80).
- Clear cutoff score (≥25) with high sensitivity and specificity for identifying complicated grief; aligns with DSM-5-TR Prolonged Grief Disorder criteria.
- Brief (19 items, <10 minutes) and simple to administer in clinical and research settings; requires no special training.
- Extensively used in outcome research, allowing comparison across studies and populations; demonstrates responsiveness to grief therapy interventions.
- Captures both cognitive (yearning, intrusive thoughts) and functional (avoidance, role impairment) dimensions of complicated grief.
Applications
- Clinical screening in primary care, psychiatric, and grief counselling services to identify bereaved individuals requiring specialized intervention.
- Outcome measurement in randomized controlled trials of grief-focused psychotherapy (e.g., Complicated Grief Therapy) and other interventions.
- Research studies examining risk and protective factors in bereavement, epidemiology of complicated grief, and prevalence in specific populations (e.g., sudden loss, loss of child).
- Longitudinal follow-up of high-risk bereaved individuals (e.g., those experiencing suicide loss or traumatic death) to monitor symptom trajectory and guide stepped-care interventions.
- Training and supervision of grief counsellors and psychotherapists as a tool for case formulation and treatment planning.
How it works
How it works
The ICG consists of 19 items rated on a 5-point Likert scale (0 = never, 1 = rarely, 2 = sometimes, 3 = often, 4 = always). Items assess grief symptoms such as yearning for the deceased, intrusive thoughts, avoidance, emotional numbness, difficulty accepting death, and impaired functioning. Respondents rate how frequently they experience each symptom during the past 2 weeks. The scale is self-administered and takes approximately 5–10 minutes to complete. No special training is required; it is suitable for use in clinical settings, research studies, and community populations.
Formula
Administer 19 items with 5-point Likert response scale
Total score is the sum of all 19 items, yielding a range of 0–76. A cutoff score of ≥25 indicates the presence of complicated grief with high sensitivity and specificity for diagnostic purposes. Scores between 25–35 suggest significant complicated grief, while scores >35 indicate severe complicated grief. Some studies use alternative cutoffs (e.g., ≥30) depending on the research context and population characteristics.
Formula
Sum all items; range 0–76. Score ≥25 indicates complicated grief
Scores <10: Minimal grief symptoms, typical bereavement response. Scores 10–24: Mild to moderate grief symptoms, within normal range. Scores 25–35: Complicated grief confirmed; significant functional impairment and persistent symptoms warrant professional intervention. Scores >35: Severe complicated grief with pronounced yearning, intrusion, and dysfunction; referral for specialized grief therapy or psychiatric evaluation recommended. Clinically, ICG scores correlate with depression, anxiety, and suicidality; high scores necessitate comprehensive mental health assessment.
Formula
Interpret based on cutoff threshold and clinical context
Common pitfalls
- Using ICG score alone as diagnostic criterion without assessing duration (6+ months post-loss) and functional impact; a high score in the first 3 months post-loss may reflect normal acute grief.
- Failing to consider contextual factors (cultural norms around grief expression, concurrent stressors, psychiatric history) that influence interpretation; same score may signify different clinical pictures in different individuals.
- Administering ICG repeatedly at short intervals (e.g., weekly) without clinical need; natural fluctuations in grief may obscure true treatment effects; recommend reassessment every 4–8 weeks.
- Misinterpreting high ICG scores as indication for antidepressants or anxiolytics alone; complicated grief primarily responds to grief-focused psychotherapy (e.g., Complicated Grief Therapy); medication is adjunctive.
Frequently asked questions
What is the difference between complicated grief (ICG ≥25) and normal grief?
Normal grief involves sadness, yearning, and temporary functional impairment that gradually improves over months to years. Complicated grief is characterized by prolonged, intense yearning, intrusive preoccupation with the deceased, avoidance, emotional numbness, and persistent impairment in work, social, or daily functioning—lasting 6+ months and causing significant distress. ICG scores <25 typically reflect normal bereavement; scores ≥25 suggest complicated grief requiring specialized intervention.
Can the ICG be used to assess grief shortly after loss (within the first 3 months)?
The ICG can be administered at any time post-loss to document symptom severity, but diagnostic interpretation differs. In the acute phase (0–3 months), elevated scores reflect normal acute grief. The diagnostic threshold (ICG ≥25 indicating complicated grief) applies when assessed 6+ months post-loss. Early administration (3–6 months) can be useful for risk stratification to identify individuals at risk for chronic complicated grief.
Is the ICG copyrighted or free to use?
The ICG is in the public domain and free to use for research and clinical purposes. No permission or licensing fee is required. The scale has been widely disseminated in academic literature and can be obtained from published sources or by contacting the authors. Some institutions may request institutional review board (IRB) approval before administering the scale in clinical or research settings.
Has the ICG been translated into other languages?
Yes, the ICG has been translated and validated in Dutch, German, Spanish, Japanese, Portuguese, Italian, and other languages. Cross-cultural studies show generally consistent factor structure and similar cutoff scores across populations, though cultural norms around grief expression may influence item endorsement. Clinicians using translated versions should consult validation studies specific to the target population.
Can the ICG be used to predict who will develop complicated grief in the future?
When administered early in bereavement (3–6 months post-loss), the ICG can help identify individuals at elevated risk for persistent complicated grief. High early scores predict slower grief resolution and higher risk for complications. However, the ICG is best used as a clinical screening tool in conjunction with contextual assessment (e.g., manner of death, presence of concurrent stressors, prior trauma history) rather than as a standalone predictive algorithm.
Related methods
Sources
Prigerson, H. G., Frank, E., Kasl, S. V., et al. (1995). Complicated grief and bereavement-related depression as distinct disorders: Preliminary empirical validation in elderly bereaved spouses. American Journal of Psychiatry, 152(1), 22–30.
Open DOI referenceCopied.